Page last updated: 2024-08-22

poloxalene and Coronary Disease

poloxalene has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrahams, SL; Buddemeier, K; Ennis, B; Hubbell, JP; Hursey, TL; Moy, J; Parrillo, JE; Rodriguez, ER; Schaer, GL1
Islamov, BI; KobrinskiÄ­, EM; Lubiako, AA; MaevskiÄ­, EI; Vorob'ev, SI1

Other Studies

2 other study(ies) available for poloxalene and Coronary Disease

ArticleYear
Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Circulation, 1994, Volume: 90, Issue:6

    Topics: Animals; Chemotaxis, Leukocyte; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; Gases; Heart; Infusions, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Neutrophils; Poloxalene; Ventricular Fibrillation; Ventricular Function, Left

1994
[Effect of proxanols on electromechanical coupling in the myocardium and their contribution to protection against ischemia by fluorocarbon emulsions].
    Vestnik Akademii meditsinskikh nauk SSSR, 1987, Issue:2

    Topics: Animals; Cardiovascular Agents; Coronary Disease; Emulsions; Fluorocarbons; Guinea Pigs; Heart; In Vitro Techniques; Myocardial Contraction; Poloxalene; Polyethylene Glycols; Rabbits; Ranidae; Rats

1987